Understanding the Eye Risk Concerns
Recent findings have raised alarming concerns about potential ophthalmic complications associated with popular diabetes medications semaglutide and tirzepatide. These incretin-based therapies, while highly effective for managing type 2 diabetes and…
This study demonstrates that adverse events (AEs) extracted using natural language processing (NLP) from clinical texts reflect the known frequencies of AEs associated with anticancer drugs. Using data from 44,502 cancer patients at a…
Continue Reading
Sheffield Teaching Hospitals NHS Foundation Trust has launched a smart tech initiative to reduce the risk of nerve damage in people living with type 2 diabetes.
The Oceanic (One-Stop Screening And Intensified Care) trial is…
Researchers at Rice University have developed a “Stimu Sock” that can help to treat balance issues and pain in the feet caused by diabetic neuropathy. The socks contain an insole that can provide haptic…
Continue Reading
